NCT05917782 - A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects | Biotech Hunter

Enrollment

324

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2023

Conditions

Healthy Adult Subjects

Interventions

BIOLOGICAL

Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)

subcutaneous injection of 2 doses on Day 1

BIOLOGICAL

Test drug (T2): CBP-201 injection (pre-filled syringe, 300 mg/2 mL)

subcutaneous injection of 1 dose on Day 1

BIOLOGICAL

Reference drug (R): CBP-201 injection (vial, 150 mg/1 mL)

subcutaneous injection of 2 doses on Day 1

Trial Locations (1)

The Second Hospital of Anhui Medical University, Hefei